At least those among you who still choose to take a flyer on Boeing will do so better informed.
With all the unknowns surrounding Boeing it's way too early to take a position in the aircraft maker; the same is not true with CVS.
Boeing's big demand driver is stinging the stocks of its biggest customers.
The stock has already tested both short-term support and potential resistance levels on Monday.
The aircraft maker has an uncanny ability to bounce back from bad news, and already is showing a tendency to do so in current trading.
Easing into the aircraft maker on its bad news is one way to go, as are call options expiring this Friday.
If longer-term investors come in to buy a sharply lower opening on the aircraft maker, then we should see prices firm.
A tragedy in the skies is taking its toll on Boeing shares.
Insider purchases have tapered off from their frenzied pace in late 2018, but here are three names where such buying is evident.
The market rally may be a rising tide, but investors should be wary of some of the stocks it has lifted up.